BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 29611406)

  • 21. Genomic study via chromosomal microarray analysis in a group of Romanian patients with obesity and developmental disability/intellectual disability.
    Micleaa D; Al-Khzouza C; Osan S; Bucerzan S; Cret V; Popp RA; Puiu M; Chirita-Emandi A; Zimbru C; Ghervan C
    J Pediatr Endocrinol Metab; 2019 Jul; 32(7):667-674. PubMed ID: 31150357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The usefulness of array comparative genomic hybridization in clinical diagnostics of intellectual disability in children.
    Bartnik M; Wiśniowiecka-Kowalnik B; Nowakowska B; Smyk M; Kędzior M; Sobecka K; Kutkowska-Kaźmierczak A; Klapecki J; Szczałuba K; Castañeda J; Własienko P; Bezniakow N; Obersztyn E; Bocian E
    Dev Period Med; 2014; 18(3):307-17. PubMed ID: 25182394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of Chromosomal Microarray in Children with Unexplained Developmental Delay/Intellectual Disability.
    Kamath V; Yoganathan S; Thomas MM; Gowri M; Chacko MP
    Fetal Pediatr Pathol; 2022 Apr; 41(2):208-218. PubMed ID: 32701375
    [No Abstract]   [Full Text] [Related]  

  • 24. [Application of chromosome microarray analysis in 489 children with developmental delay/intellectual disability].
    Wang R; Lei T; Fu F; Li R; Jing X; Yang X; Pan M; Li D; Liao C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Aug; 34(4):528-533. PubMed ID: 28777852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Copy number variants analysis in a cohort of isolated and syndromic developmental delay/intellectual disability reveals novel genomic disorders, position effects and candidate disease genes.
    Di Gregorio E; Riberi E; Belligni EF; Biamino E; Spielmann M; Ala U; Calcia A; Bagnasco I; Carli D; Gai G; Giordano M; Guala A; Keller R; Mandrile G; Arduino C; Maffè A; Naretto VG; Sirchia F; Sorasio L; Ungari S; Zonta A; Zacchetti G; Talarico F; Pappi P; Cavalieri S; Giorgio E; Mancini C; Ferrero M; Brussino A; Savin E; Gandione M; Pelle A; Giachino DF; De Marchi M; Restagno G; Provero P; Cirillo Silengo M; Grosso E; Buxbaum JD; Pasini B; De Rubeis S; Brusco A; Ferrero GB
    Clin Genet; 2017 Oct; 92(4):415-422. PubMed ID: 28295210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Application of chromosomal microarray analysis for the diagnosis of children with intellectual disability/developmental delay and a normal karytype].
    Hu T; Zhu H; Zhang Z; Wang J; Liu H; Zhang X; Zhang H; Du Z; Li L; Wang H; Liu S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Apr; 34(2):169-172. PubMed ID: 28397211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive diagnostic value for the clinical features accompanying intellectual disability in children with pathogenic copy number variations: a multivariate analysis.
    Caramaschi E; Stanghellini I; Magini P; Giuffrida MG; Scullin S; Giuva T; Bergonzini P; Guerra A; Paolucci P; Percesepe A
    Ital J Pediatr; 2014 Apr; 40():39. PubMed ID: 24775911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromosomal microarray in postnatal diagnosis of congenital anomalies and neurodevelopmental disorders in Serbian patients.
    Perovic D; Damnjanovic T; Jekic B; Dusanovic-Pjevic M; Grk M; Djuranovic A; Rasic M; Novakovic I; Maksimovic N
    J Clin Lab Anal; 2022 Jun; 36(6):e24441. PubMed ID: 35441737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Considering specific clinical features as evidence of pathogenic copy number variants.
    Preiksaitiene E; Molytė A; Kasnauskiene J; Ciuladaite Z; Utkus A; Patsalis PC; Kučinskas V
    J Appl Genet; 2014 May; 55(2):189-96. PubMed ID: 24535828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic yield of microarrays in individuals with non-syndromic developmental delay and intellectual disability.
    Oğuz S; Arslan UE; Kiper PÖŞ; Alikaşifoğlu M; Boduroğlu K; Utine GE
    J Intellect Disabil Res; 2021 Dec; 65(12):1033-1048. PubMed ID: 34661940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost Effectiveness of Karyotyping, Chromosomal Microarray Analysis, and Targeted Next-Generation Sequencing of Patients with Unexplained Global Developmental Delay or Intellectual Disability.
    Li Y; Anderson LA; Ginns EI; Devlin JJ
    Mol Diagn Ther; 2018 Feb; 22(1):129-138. PubMed ID: 29209992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Value of copy number variation analysis and chromosomal karyotyping for the diagnosis of children with intellectual disability/developmental delay].
    Lin M; Xue H; Wang Y; Huang H; Fu M; Guo N; Xu L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Mar; 38(3):228-231. PubMed ID: 33751530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Application of single nucleotide polymorphism-microarray and target gene sequencing in the study of genetic etiology of children with unexplained intellectual disability or developmental delay].
    Gao ZJ; Jiang Q; Cheng DZ; Yan XX; Chen Q; Xu KM
    Zhonghua Er Ke Za Zhi; 2016 Oct; 54(10):740-745. PubMed ID: 27784475
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical utility and cost-effectiveness analysis of chromosome testing concomitant with chromosomal microarray of patients with constitutional disorders in a U.S. academic medical center.
    Su M; Page S; Haag M; Swisshelm K; Hennerich D; Graw S; LeRoux J; Brzeskiewicz P; Svihovec S; Bao L
    J Genet Couns; 2022 Apr; 31(2):364-374. PubMed ID: 34397147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Additive Diagnostic Yield of Homozygosity Regions Identified During Chromosomal microarray Testing in Children with Developmental Delay, Dysmorphic Features or Congenital Anomalies.
    Ali MAM; Hassan AM; Saafan MA; Abdelmagid AA
    Biochem Genet; 2020 Feb; 58(1):74-101. PubMed ID: 31273557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent benign copy number variants & issues in interpretation of variants of unknown significance identified by cytogenetic microarray in Indian patients with intellectual disability.
    Boggula VR; Agarwal M; Kumar R; Awasthi S; Phadke SR
    Indian J Med Res; 2015 Dec; 142(6):699-712. PubMed ID: 26831419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromosomal microarrays testing in children with developmental disabilities and congenital anomalies.
    Lay-Son G; Espinoza K; Vial C; Rivera JC; Guzmán ML; Repetto GM
    J Pediatr (Rio J); 2015; 91(2):189-95. PubMed ID: 25458876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New insights in the interpretation of array-CGH: autism spectrum disorder and positive family history for intellectual disability predict the detection of pathogenic variants.
    Cappuccio G; Vitiello F; Casertano A; Fontana P; Genesio R; Bruzzese D; Ginocchio VM; Mormile A; Nitsch L; Andria G; Melis D
    Ital J Pediatr; 2016 Apr; 42():39. PubMed ID: 27072107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A clear bias in parental origin of de novo pathogenic CNVs related to intellectual disability, developmental delay and multiple congenital anomalies.
    Ma R; Deng L; Xia Y; Wei X; Cao Y; Guo R; Zhang R; Guo J; Liang D; Wu L
    Sci Rep; 2017 Mar; 7():44446. PubMed ID: 28322228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromosomal Microarray Analysis of Consecutive Individuals with Autism Spectrum Disorders Using an Ultra-High Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders.
    Ho KS; Wassman ER; Baxter AL; Hensel CH; Martin MM; Prasad A; Twede H; Vanzo RJ; Butler MG
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.